User profiles for Raj Vuppalanchi

Raj Vuppalanchi

Professor of Medicine, Indiana University School of Medicine
Verified email at iu.edu
Cited by 12735

[PDF][PDF] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

R Vuppalanchi, N Chalasani - Hepatology, 2009 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liver
disease in the western world. It is now recognized that these patients have myriad of …

[HTML][HTML] Effects of belapectin, an inhibitor of galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension

…, MF Abdelmalek, G Garcia-Tsao, R Vuppalanchi… - Gastroenterology, 2020 - Elsevier
Background & Aims Increased levels of galectin 3 have been associated with nonalcoholic
steatohepatitis (NASH) and contribute to toxin-induced liver fibrosis in mice. GR-MD-02 (…

Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study

…, T Schiano, J Serrano, AH Sherker, R Vuppalanchi… - Gastroenterology, 2015 - Elsevier
Background & Aims The Drug-Induced Liver Injury Network is conducting a prospective
study of patients with DILI in the United States. We present characteristics and subgroup …

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials

…, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi… - Journal of …, 2020 - Elsevier
Background & Aims Apoptosis signal-regulating kinase 1 (ASK1) plays a key role in hepatocyte
injury, inflammation, and fibrosis in non-alcoholic steatohepatitis (NASH). We evaluated …

Dyslipidemia in patients with nonalcoholic fatty liver disease

H Chatrath, R Vuppalanchi… - Seminars in liver …, 2012 - thieme-connect.com
Raj VuppalanchiVuppalanchi serves on the speaker's bureau for Vertex and Genentech
and … 63 Vuppalanchi R, Teal E, Chalasani N. Patients with elevated baseline liver enzymes do …

Therapeutic pipeline in nonalcoholic steatohepatitis

R Vuppalanchi, M Noureddin, N Alkhouri… - Nature Reviews …, 2021 - nature.com
Our understanding of nonalcoholic fatty liver disease pathophysiology continues to advance
rapidly. Accordingly, the field has moved from describing the clinical phenotype through the …

Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease

MS Siddiqui, R Vuppalanchi, ML Van Natta… - Clinical …, 2019 - Elsevier
Background & Aims Vibration-controlled transient elastography (VCTE), which measures liver
stiffness, has become an important tool for evaluating patients with nonalcoholic fatty liver …

Liver injury from herbals and dietary supplements in the US Drug‐Induced Liver Injury Network

…, A Stolz, J Talwalkar, M Vega, R Vuppalanchi - …, 2014 - Wiley Online Library
The Drug‐Induced Liver Injury Network (DILIN) studies hepatotoxicity caused by
conventional medications as well as herbals and dietary supplements (HDS). To characterize …

Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease

S Tandra, MM Yeh, EM Brunt, R Vuppalanchi… - Journal of …, 2011 - Elsevier
BACKGROUND & AIMS: Liver biopsies from patients with nonalcoholic fatty liver disease (NAFLD)
sometimes exhibit non-zonal aggregates of hepatocytes with microvesicular steatosis…

High‐quality diet, physical activity, and college education are associated with low risk of NAFLD among the US population

E Vilar‐Gomez, LD Nephew, R Vuppalanchi… - …, 2022 - Wiley Online Library
Background and Aims The effects of diet quality (DQ), physical activity (PA), and socioeconomic
status (SES) on the risk of NAFLD are unclear. We examined the association among DQ, …